Risk of infections in rheumatoid arthritis patients treated with tocilizumab
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of infections in rheumatoid arthritis patients treated with tocilizumab
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 51, Issue 5, Pages 852-857
Publisher
Oxford University Press (OUP)
Online
2011-08-25
DOI
10.1093/rheumatology/ker223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
- (2012) Teresa A Simon et al. ARTHRITIS RESEARCH & THERAPY
- Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia
- (2010) J. JOHNSTONE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
- (2010) Amy Linsky ARCHIVES OF INTERNAL MEDICINE
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Acid-suppressive Drugs and Community-acquired Pneumonia
- (2010) Luis Alberto García Rodríguez et al. EPIDEMIOLOGY
- Observational Studies of Infections in Rheumatoid Arthritis: A Metaanalysis of Tumor Necrosis Factor Antagonists
- (2010) S. BERNATSKY et al. JOURNAL OF RHEUMATOLOGY
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
- (2010) X. Mariette et al. RHEUMATOLOGY
- Tocilizumab
- (2009) Vicki Oldfield et al. DRUGS
- Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
- (2009) Yasuhiko Hirabayashi et al. RHEUMATOLOGY INTERNATIONAL
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
- (2008) N Nishimoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
- (2008) Diane Lacaille et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started